Allergan (AGN) Q1 2012 Earnings Call May 02, 2012 11:00 am ET Executives James M. Hindman - Chief Financial Officer David E.I. Pyott - Chairman, Chief Executive officer and President Jeffrey L. Edwards - Chief Financial Officer and Executive Vice President of Finance & Business Development Joann Bradley - Analysts Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Gregory Waterman - Goldman Sachs Group Inc., Research Division Gary Nachman - Susquehanna Financial Group, LLLP, Research Division Marc Goodman - UBS Investment Bank, Research Division Douglas D. Tsao - Barclays Capital, Research Division David G. Buck - The Buckingham Research Group Incorporated Annabel Samimy - Stifel, Nicolaus & Co., Inc., Research Division John T. Boris - Citigroup Inc, Research Division Seamus Fernandez - Leerink Swann LLC, Research Division Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division Gregory B. Gilbert - BofA Merrill Lynch, Research Division Shibani Malhotra - RBC Capital Markets, LLC, Research Division David Risinger - Morgan Stanley, Research Division Ken Cacciatore - Cowen and Company, LLC, Research Division Catherine J. Arnold - Crédit Suisse AG, Research Division Steve Willoughby - Cleveland Research Company Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division David Amsellem - Piper Jaffray Companies, Research Division PresentationOperator
Hello, and welcome to the Allergan First Quarter 2012 Earnings Call. [Operator Instructions] At the request of the company, today's conference is being recorded. If anyone has any objections, you may disconnect at this time. I would like to introduce today's conference host, Mr. Jim Hindman, Senior Vice President, Treasury, Risk and Investor Relations. Sir, you may begin. James M. Hindman Thank you, Terry. Good morning. With me for today's conference call is David Pyott, Chairman of the Board, President and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial Officer; Dr. Scott Whitcup, Executive Vice President, Research and Development, Chief Scientific Officer; and Jim Barlow, Senior Vice President and Corporate Controller.